Skip to contentCASH HARVEY B — ARGONAUT GROUP INC insider: 213 transactions · InsiderLensCASH HARVEY B
- 10% owner at CORGENTECH INC · on record since Mar 31, 2006
- Director at CIENA CORP · on record since Mar 17, 2006
- Director at ARGONAUT GROUP INC · on record since Jun 18, 2007
- Director at SILICON LABORATORIES INC · on record since Mar 2, 2006
- 10% owner at METABASIS THERAPEUTICS INC · on record since May 24, 2006
- Director at AIRSPAN NETWORKS INC · on record since Jun 2, 2006
- Director at I2 TECHNOLOGIES INC · on record since Jun 2, 2006
- Director at FIRST ACCEPTANCE CORP /DE/ · on record since Nov 13, 2006
- Director at PXRE GROUP LTD · on record since Aug 7, 2007
- 10% owner at EnteroMedics Inc · on record since Nov 21, 2007
- Director at STAKTEK HOLDINGS INC · on record since Jun 25, 2008
- Managing Director at Trius Therapeutics Inc · on record since Aug 10, 2010
- 10% owner at MACROGENICS INC · on record since Oct 18, 2013
- Former 10% Owner at EPOCRATES INC · on record since Feb 7, 2011
- 10% owner at EPOCRATES INC · on record since Feb 1, 2011
- Director at MICROTUNE INC · on record since Sep 19, 2003
- 10% owner at NOVACEA INC · on record since Sep 23, 2011
- 10% owner at TESARO, Inc. · on record since Jun 27, 2012
- 10% owner at APPLIED GENETIC TECHNOLOGIES CORP · on record since Mar 26, 2014
- 10% owner at INTRALASE CORP · on record since Oct 6, 2004
- 10% owner at MYOGEN INC · on record since Jun 30, 2005
Insider trading activity of CASH HARVEY B
- Transactions on record
- 213
- since Jul 29, 2003
- Open-market buys
- 5
- $1.3M
- Open-market sells
- 50
- $16.6M
- Companies traded
- 11
- last filing Apr 5, 2018
Figures computed from official regulatory filings — methodology.
Companies where CASH HARVEY B has traded
Track record of CASH HARVEY B
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Apr 1, 2014
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of CASH HARVEY B
Co-insiders of CASH HARVEY B
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
7 tx · Aug 2, 2005
INTERWEST INVESTORS Q VIII LPAPPLIED GENETIC TECHNOLOGIES CORP +4
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 5, 2018 | Award | 7,626 | 0.00 USD | $0 | SEC |
| Dec 5, 2017 | Other | -2,457 | 61.00 USD | $149.9K | SEC |
| Dec 5, 2017 | Exercise | 2,457 | 0.00 USD | $0 | SEC |
| Dec 5, 2017 | ExerciseD | -2,457 | — | — | SEC |
| Nov 16, 2017 | Other | -8,857 | 59.35 USD | $525.7K | SEC |
| Nov 16, 2017 | Exercise | 6,655 | 33.95 USD | $225.9K | SEC |
| Nov 16, 2017 | Exercise | 6,655 | 21.90 USD | $145.7K | SEC |
| Nov 16, 2017 | ExerciseD | -6,655 | 0.00 USD | $0 | SEC |
| Nov 16, 2017 | ExerciseD | -6,655 | 0.00 USD | $0 | SEC |
| Nov 16, 2017 | ExerciseD | -6,655 | 0.00 USD | $0 | SEC |
| Nov 16, 2017 | Exercise | 6,655 | 23.11 USD | $153.8K | SEC |
| Nov 9, 2017 | AwardD | 11 | — | — | SEC |
| Aug 9, 2017 | AwardD | 11 | — | — | SEC |
| Jun 5, 2017 | AwardD | 10 | — | — | SEC |
| Jun 5, 2017 | Award | 1,120 | 0.00 USD | $0 | SEC |
| May 11, 2017 | Award | 1,000 | 0.00 USD | $0 | SEC |
| Mar 27, 2017 | Award | 8,055 | 0.00 USD | $0 | SEC |
| Feb 22, 2017 | AwardD | 9 | — | — | SEC |
| Jan 9, 2017 | Sell | -700 | 24.28 USD | $17K | SEC |
| Dec 1, 2016 | Other | -2,492 | 63.85 USD | $159.1K | SEC |
| Dec 1, 2016 | Exercise | 6,655 | 23.90 USD | $159.1K | SEC |
| Dec 1, 2016 | ExerciseD | 6,655 | 0.00 USD | $0 | SEC |
| Dec 1, 2016 | Sell | -4,163 | 63.95 USD | $266.2K | SEC |
| Nov 17, 2016 | AwardD | 8 | — | — | SEC |
| Aug 4, 2016 | AwardD | 10 | — | — | SEC |